Phase II Neoadjuvant in Inflammatory Breast Cancer

NCT00756470 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

15

Enrollment

OTHER

Sponsor class

Stopped Slow accrual.

Conditions

Breast Cancer

Interventions

DRUG: Lapatinib
DRUG: Paclitaxel
DRUG: 5-Fluorouracil (5-FU)
DRUG: Epirubicin
DRUG: Cyclophosphamide

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]